Search
01/06/2024
Cardiometabolic sex-specific response to a natural polysaccharide in individuals with obesity
Villaplana, VDS, Muñoz, N, Puntes, M, Badimón, L, Padró, T. Cardiometabolic sex-specific response to a natural polysaccharide in individuals with obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
24/04/2024
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug
Pieren, M, Gutiérrez-Solana, AA, Arbós, RMA, Boyle, GW, Davila, M, Davy, M, Gitzinger, M, Husband, L, Martínez-Martínez, MS, Mazarro, DO, Pefani, E, Penman, SL, Remuiñán, MJ, Vlasakakis, G, Zeitlinger, M, Dale, GE. First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(6)DOI:10.1093/jac/dkae107. PMID:38656557. IF:3.600(Q2/3D).
25/03/2024
Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Padro, T, Santisteban, V, Huedo, P, Puntes, M, Aguiló, M, Espadaler-Mazo, J, Badimon, L. Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans. CARDIOVASCULAR RESEARCH. 2024; 120(7)DOI:10.1093/cvr/cvae061. PMID:38525555. IF:13.300(Q1/1D).
11/10/2023
Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units
Moraga P., Prieto P., Conradie A., Benhayoun M., Rousell V., Davy M., Fuhr U., Antonijoan Arbos R., Abad-Santos F., Portolés A., Van Duinen J., Carcas A.J., Borobia A.M.. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. CTS-Clinical and Translational Science. 2023; 16(12)DOI:10.1111/cts.13655. PMID:37818923. IF:3.100(Q2/5D).
01/02/2023
The role of opioid transmission in music-induced pleasure
Mas-Herrero, E, Ferreri, L, Cardona, G, Zatorre, RJ, Pla-Junca, F, Antonijoan, RM, Riba, J, Valle, M, Rodriguez-Fornells, A. The role of opioid transmission in music-induced pleasure. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2023; 1520(1)DOI:10.1111/nyas.14946. PMID:36514207. IF:4.100(Q1/2D).
01/01/2022
A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
Soria J.M., Mojal S., Martinez-Perez A., Acosta F.R., López S., Miqueleiz S., Rodriguez D., Quijada M.A., Cardenas A., Vidal F., Remacha A., Antonijoan R.M., Souto J.C.. A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis. HAEMATOLOGICA. 2022; 107(9)DOI:10.3324/haematol.2022.281068. PMID:35545920. IF:10.100(Q1/2D).